Fibrotic liver microenvironment promotes Dll4 and SDF-1-dependent T-cell lineage development.
Zheng GongBingxue ShangYunpeng ChuXiaodong ChenQing LiKeli LiuYongjing ChenYin HuangYanyan HanQianwen ShangZhiyuan ZhengLin SongYanan LiRui LiuChenchang XuXiaoren ZhangBaochi LiuLuowei WangChangshun ShaoYing WangYufang ShiPublished in: Cell death & disease (2019)
The reconstitution of the T-cell repertoire and quantity is a major challenge in the clinical management of HIV infection/AIDS, cancer, and aging-associated diseases. We previously showed that autologous bone marrow transfusion (BMT) via the hepatic portal vein could effectively restore CD4+ T-cell count in AIDS patients also suffering from decompensated liver cirrhosis. In the current study, we characterized T-cell reconstitution in a mouse model of liver fibrosis induced by CCl4 and found that T-cell reconstitution after BMT via hepatic portal vein was also greatly enhanced. The expression of Dll4 (Delta-like 4), which plays an important role in T-cell progenitor expansion, was elevated in hepatocytes of fibrotic livers when compared to normal livers. This upregulation of Dll4 expression was found to be induced by TNFα in an NFκB-dependent manner. Liver fibroblasts transfected with Dll4 (LF-Dll4) also gained the capacity to promote T-cell lineage development from hematopoietic stem cells (HSCs), resulting in the generation of DN2 (CD4 and CD8 DN 2) and DN3 T-cell progenitors in vitro, which underwent a normal maturation program when adoptively transferred into Rag-2 deficient hosts. We also demonstrated a pivotal role of SDF-1 produced by primary liver fibroblasts (primary LF) in T-lineage differentiation from HSCs. These results suggest that Dll4 and SDF-1 in fibrotic liver microenvironment could promote extrathymic T-cell lineage development. These results expand our knowledge of T-cell development and reconstitution under pathological conditions.
Keyphrases
- stem cells
- bone marrow
- liver fibrosis
- poor prognosis
- mouse model
- systemic sclerosis
- heart failure
- healthcare
- end stage renal disease
- signaling pathway
- ejection fraction
- idiopathic pulmonary fibrosis
- cell proliferation
- newly diagnosed
- antiretroviral therapy
- chronic kidney disease
- quality improvement
- immune response
- acute kidney injury
- binding protein
- inflammatory response
- childhood cancer
- toll like receptor
- platelet rich plasma